SCHEMBL14616506

SCHEMBL14616506

CC(=O)Cc1c(C)ccc(-c2ccc(Cl)cc2)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.38
SUCNR1 Q9BXA5 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
CA12 O43570 2/20 0.37
CA9 Q16790 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
DHODH Q02127 1/20 0.36
RAB9A P51151 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2543855 0.88 PTGDR2 (0.41) PTGDR2SUCNR1KDM4EMEN1KMT2A
SCHEMBL12479163 0.88 CA12 (0.47) PTGDR2SUCNR1KDM4EMEN1KMT2A
SCHEMBL14089367 0.84 KDM4E (0.45) SUCNR1KDM4EMEN1KMT2AALDH1A1
SCHEMBL14089363 0.81 KMT2A (0.36) PTGDR2SUCNR1KDM4EMEN1KMT2A
SCHEMBL14616507 0.77 PTGDR2 (0.38) PTGDR2KDM4EMEN1KMT2AALDH1A1
SCHEMBL861566 0.72 PTGS1 (0.51) PTGDR2KDM4EMEN1KMT2AALDH1A1
SCHEMBL14616505 0.72 SUCNR1 (0.43) PTGDR2SUCNR1KDM4EMEN1KMT2A
SCHEMBL1004061 0.72 MAPT (0.47) PTGDR2MEN1KMT2ACA12CA9
SCHEMBL16273898 0.71 HTR1D (0.41) KDM4EMEN1KMT2AALDH1A1CYP1A2
SCHEMBL19289813 0.69 AKR1B1 (0.38) MEN1KMT2AALDH1A1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018202-A1 4-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives BAYER CROPSCIENCE AG (DE) 2013-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018202-A1 4-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives DDT, CYP4X1, HPD PTGDR2 1744/4885SUCNR1 3595/4885KDM4E 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.